Related Experiment Video

Updated: Jun 28, 2026

Isolation of Group 2 Innate Lymphoid Cells from Mouse Nasal Mucosa to Detect the Expression of CD226
08:30

Isolation of Group 2 Innate Lymphoid Cells from Mouse Nasal Mucosa to Detect the Expression of CD226

Published on: May 10, 2022

A novel ING2 isoform, ING2b, synergizes with ING2a to prevent cell cycle arrest and apoptosis

Motoko Unoki1, Kensuke Kumamoto, Ana I Robles

  • 1Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, NIH, 37 Convent Dr., Bldg. 37, Rm. 3068, Bethesda, MD 20892, USA.

FEBS Letters
|October 28, 2008
PubMed

Insights

Researchers discovered a new ING2b protein isoform that, along with ING2a, prevents cell cycle arrest and apoptosis. These ING2 isoforms may play a role in chemoresistance, offering new therapeutic targets.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • The inhibitor of growth family member 2 (ING2) gene encodes multiple isoforms.
  • ING2a and ING2b are known isoforms with distinct functional properties.
  • The role of ING2 isoforms in cell cycle regulation and response to p53 is not fully understood.

Purpose of the Study:

  • To identify and characterize a novel ING2 isoform, ING2b.
  • To investigate the distinct roles of ING2a and ING2b in cell growth, cell cycle control, and apoptosis.
  • To elucidate the relationship between ING2 isoforms, p53, and potential chemotherapeutic resistance.

Main Methods:

  • Isoform-specific RNA interference (knockdown) was employed to target ING2a and ING2b.
  • Cell growth, cell cycle progression, and apoptosis assays were performed.
  • Analysis of p53 binding sites in the ING2 promoter regions was conducted.

Main Results:

  • A novel ING2 isoform, ING2b, was identified, lacking the p53 binding domain present in ING2a.
  • ING2a expression was suppressed by p53 activation, while ING2b remained unaffected.
  • ING2a knockdown inhibited cell growth only in the presence of p53.
  • Knockdown of both ING2a and ING2b induced cell cycle arrest and apoptosis independently of p53.

Conclusions:

  • ING2a and ING2b exhibit compensatory roles in preventing cell cycle arrest and apoptosis.
  • These ING2 isoforms may contribute to the development of chemotherapeutic resistance.
  • Targeting ING2 isoforms presents a potential strategy for cancer therapy.

More Related Videos

Analysis of Cell Cycle Position in Mammalian Cells12:19

Analysis of Cell Cycle Position in Mammalian Cells

Published on: January 21, 2012

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Cell Cycle Control System01:28

The Cell Cycle Control System

The cell cycle regulation directs how a cell proceeds from one phase to the next and begins mitosis. The cell cycle control system includes intracellular regulatory molecules and external triggers. They provide "stop" or "advance" signals and operate at specific cell cycle stages termed checkpoints to ensure that a particular process is completed before the cell advances to the next phase.
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and function at the cell...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...